Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

We have observed 2 EP applications Laurence David Scott Gainey has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14153398

(4-Tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives

IPC classification:
A61K 31/496, C07D 417/12, C07D 241/04, A61P 25/00
Applicant:
AstraZeneca AB
Agent:
Laurence David Scott Gainey, AstraZeneca AB
Agent:
Laurence David Scott Gainey, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13850047

CANCER TREATMENT

IPC classification:
C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Applicant:
Isis Pharmaceuticals, Inc.
Agent:
Laurence David Scott Gainey, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature